RA
BIOSW

Ramius Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Ramius Advisors’s Portfolio BIOSW Stock Details BIOSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-196,073
Closed -$16K – 221
2022
Q3 		$16K Hold
196,073
– – 0.01% 94
2022
Q2 		$27K Buy
+196,073
New +$36.6K 0.01% 110

Other funds holding BIOSW

MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Ramius Advisors's BIOSW Position: Q4 2022 in Review

Ramius Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2022, closing a stake of 196,073 shares — an estimated $16K sold.

Ramius Advisors first reported a position in BIOSW in Q2 2022 and held it in 2 quarters. The position peaked at $27K in Q2 2022. 45 funds tracked by Wall St. Rank hold BIOSW as of Q4 2022.

  • Ramius Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
  • Ramius Advisors sold 196,073 BioPlus Acquisition Corp. Warrants shares in Q4 2022, an estimated $16K.
  • Ramius Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q2 2022 and held it in 2 quarters.
  • Ramius Advisors's BioPlus Acquisition Corp. Warrants position peaked at $27K in Q2 2022.
  • 45 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2022.

Based on Ramius Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.